FSD Pharma Congratulates High Tide on the Resumption of Retail Cannabis Licensing by AGLC in Alberta

About this update from Quantum Biopharma Ltd. Subordinate Voting Shares Class B

[{"type":"text","content":"\n\n\n\nFSD Pharma Congratulates High Tide on the Resumption of Retail Cannabis Licensing by AGLC in Alberta\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\n\nCanada NewsWire\nTORONTO, May 31, 2019\n\n\n\nTORONTO, May 31, 2019 /CNW/ - FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (\"FSD\" or the \"Company\") would like to congratulate High Tide Inc. (CSE: HITI) (OTCQB: HITIF) (FRA: 2LY) (\"High Tide\") on the recent announcement from Alberta Gaming, Liquor and Cannabis lifting the moratorium on issuing cannabis licenses and accepting license applications. The announcement is an encouraging sign of steadily improving cannabis supply levels in Alberta and is a positive step for companies like High Tide that have numerous stores ready and waiting to retail cannabis products.\n\n \n \n\n \nAs a strategic investor in High Tide, FSD Pharma is pleased to see changes that will support the continued growth and success of the cannabis industry as well as the companies in which it is invested. FSD Pharma will remain a supporter of High Tide and will continue to work collaboratively with it as a cannabis retailer enhanced by the manufacturing and wholesale distribution of smoking accessories and cannabis lifestyle products.\n\"In addition to High Tide's existing retail locations in Alberta, Saskatchewan, and Ontario, this lifting of the moratorium will allow the company to increase its return on the investments it has made on infrastructure. This will offer a number of new and exciting retail locations for Albertans and we see further value in our partner High Tide,\" said Dr. Raza Bokhari, FSD Executive Co-Chairman & Chief Executive Officer.\nFor more information on FSD Pharma: https://fsdpharma.com\nAbout FSD Pharma\nFSD Pharma is focused on the development of the highest quality indoor grown, pharmaceutical grade cannabis and on the research and development of novel cannabinoid-based treatments for several central nervous system disorders, including chronic pain, fibromyalgia and irritable bowel syndrome. The Company has 25,000 square feet that is licensed at its...

More updates from Quantum Biopharma Ltd. Subordinate Voting Shares Class B